Literature DB >> 10485492

The role of hyaluronan and interleukin 8 in the migration of chronic lymphocytic leukemia cells within lymphoreticular tissues.

K J Till1, M Zuzel, J C Cawley.   

Abstract

Malignant lymphocyte migration into and within lymphoreticular tissue is an important aspect of chronic lymphocytic leukemia (CLL), yet little is known about the processes involved. Our previous studies of integrin expression and function in CLL have shown that the abnormal cells are relatively nonadhesive and nonmotile on the protein ligands of these receptors. Here we show that CLL cells adhere to a non-protein ligand, hyaluronan (HA), and become motile (as assessed by both Boyden chamber migration and time-lapse video microscopy) on this ligand when stimulated with interleukin (IL) 8. The combined presence of HA and IL-8 was essential for this motility because IL-8 did not stimulate movement on other surfaces. Blocking antibodies showed that this motility is mediated by the receptor for HA-mediated motility (RHAMM), without the involvement of CD44. Moreover, confocal microscopy showed a polarized distribution of RHAMM and F-actin, but not CD44, in cells which had become motile on HA in the presence of IL-8. Immunohistochemical studies of nodes and spleen demonstrated an abundant reticular network of HA-containing fibers throughout diseased nodes and in splenic white pulp. The splenic red pulp and the luminal surface of high endothelial venules lacked HA. IL-8 was ubiquitously present in these tissues. CLL cells were shown to move spontaneously on fibroblast monolayers derived from lymphoid tissue; this movement was largely blocked by hyaluronidase or anti-RHAMM or anti-IL-8 antibodies. These studies indicate that IL-8-induced motility on HA is likely to be important for CLL cell migration through lymphoid tissue.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10485492

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

Review 1.  Targeted Therapy in Chronic Lymphocytic Leukemia.

Authors:  Thomas J Kipps; Michael Y Choi
Journal:  Cancer J       Date:  2019 Nov/Dec       Impact factor: 3.360

2.  Hyaluronate receptors mediating glioma cell migration and proliferation.

Authors:  Y Akiyama; S Jung; B Salhia; S Lee; S Hubbard; M Taylor; T Mainprize; K Akaishi; W van Furth; J T Rutka
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

3.  A novel CD44-binding peptide from the pro-matrix metalloproteinase-9 hemopexin domain impairs adhesion and migration of chronic lymphocytic leukemia (CLL) cells.

Authors:  Estefanía Ugarte-Berzal; Elvira Bailón; Irene Amigo-Jiménez; Juan Pablo Albar; José A García-Marco; Angeles García-Pardo
Journal:  J Biol Chem       Date:  2014-04-16       Impact factor: 5.157

4.  Microvessel density, endothelial-cell proliferation and carbonic anhydrase IX expression in haematological malignancies, bone-marrow metastases and monoclonal gammopathy of undetermined significance.

Authors:  H R De Raeve; P B Vermeulen; K Vanderkerken; A L Harris; E Van Marck
Journal:  Virchows Arch       Date:  2004-05-28       Impact factor: 4.064

5.  Immune responses to RHAMM in patients with acute myeloid leukemia after chemotherapy and allogeneic stem cell transplantation.

Authors:  R Casalegno-Garduño; C Meier; A Schmitt; A Spitschak; I Hilgendorf; S Rohde; C Hirt; M Freund; B M Pützer; M Schmitt
Journal:  Clin Dev Immunol       Date:  2012-06-06

Review 6.  The Role of CD44 in the Pathophysiology of Chronic Lymphocytic Leukemia.

Authors:  Julia Christine Gutjahr; Richard Greil; Tanja Nicole Hartmann
Journal:  Front Immunol       Date:  2015-04-20       Impact factor: 7.561

Review 7.  Extracellular matrix and its therapeutic potential for cancer treatment.

Authors:  Jiacheng Huang; Lele Zhang; Dalong Wan; Lin Zhou; Shusen Zheng; Shengzhang Lin; Yiting Qiao
Journal:  Signal Transduct Target Ther       Date:  2021-04-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.